Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Sept 2026 for Integra Lifesciences Holdings CORP, €21k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Chantal Veillon-Berteloot: trading record in brief
All filings by Chantal Veillon-Berteloot on record concern Integra Lifesciences Holdings Corp. Over a trading history stretching from 1 September 2023 to 1 September 2026, the count stands at 7 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 4 September 2026, the filings show a share grant worth €21k in Integra Lifesciences Holdings Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Chantal Veillon-Berteloot
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
1,455 shares@ US$16.620.0019% mcap15.9% of flowCommon StockSEC:0001990905-26-000004:0
5,420 shares@ US$9.6134.3% of flowCommon StockSEC:0001990905-26-000002:0
2,139 shares@ US$15.1321.1% of flowCommon StockSEC:0000917520-25-000083:0
524 shares@ US$23.958.8% of flowCommon StockSEC:0000917520-25-000025:0
1,412 shares@ US$20.3419.9% of flowCommon StockSEC:0000917520-24-000096:0
3,475 shares0Common StockSEC:0000917520-24-000033:0
4,678 shares0Common StockSEC:0001209191-23-048135:0
7 of 7 declarations
